Cargando…
Association between ceramides and coronary artery stenosis in patients with coronary artery disease
BACKGROUND: Coronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma cer...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315545/ https://www.ncbi.nlm.nih.gov/pubmed/32586390 http://dx.doi.org/10.1186/s12944-020-01329-0 |
_version_ | 1783550277580750848 |
---|---|
author | Tu, Chenchen Xie, Lan Wang, Zhenjie Zhang, Lili Wu, Hongmei Ni, Wei Li, Caixia Li, Lin Zeng, Yong |
author_facet | Tu, Chenchen Xie, Lan Wang, Zhenjie Zhang, Lili Wu, Hongmei Ni, Wei Li, Caixia Li, Lin Zeng, Yong |
author_sort | Tu, Chenchen |
collection | PubMed |
description | BACKGROUND: Coronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma ceramide levels and the severity of stenosis, together with the onset of diseases. This aim of the present study was to investigate the association betweencertain ceramide species, coronary artery stenosis and acute coronary syndrome. METHODS: Five hundred fifty-three patients with definite or suspected CAD were recruited and received angiography. Subjects were assigned into 4 groups according to the severity of coronary artery stenosis. The measurements of 4 plasma ceramide species, namely, Cer (d18:1/16:0), Cer (d18:1/18:0), Cer (d18:1/24:1), Cer (d18:1/24:0) were carried out by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the ratio of Cer (d18:1/16:0), Cer (d18:1/18:0) and Cer (d18:1/24:1) to Cer (18:1/24:0), respectively, were calculated as index to evaluate the association between plasma ceramides levels and coronary artery stenosis. Multiple logistic regression analysis was used to establish the prognostic model for the prediction of ACS risk. RESULTS: After the adjustment by multiple clinical risk factors including age, gender, pre-existing myocardial/cerebral infarction, hemoglobin A1c% (HbA1c%), smoking and the diagnosis during index hospitalization, multiple logistic regression analysis showed that the high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c%, unstable angina (UAP) and acute myocardial infarction (AMI) diagnosis (compared with atherosclerosis) during index hospitalization were associated with more severe coronary artery stenosis. Furthermore, the prognostic model was established after adjustment of risk factors and the area under curve (AUC) of receiver operating characteristics (ROC) for the prognostic model was 0.732 and 95% CI was 0.642–0.822. CONCLUSION: The severity of coronary artery stenosis is associated with high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c% and AMI. Although the reported prognostic model showed a good discrimination, further investigation on long term MACE is needed to evaluate the role of ceramide for the prediction of MACE risk. |
format | Online Article Text |
id | pubmed-7315545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73155452020-06-25 Association between ceramides and coronary artery stenosis in patients with coronary artery disease Tu, Chenchen Xie, Lan Wang, Zhenjie Zhang, Lili Wu, Hongmei Ni, Wei Li, Caixia Li, Lin Zeng, Yong Lipids Health Dis Research BACKGROUND: Coronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma ceramide levels and the severity of stenosis, together with the onset of diseases. This aim of the present study was to investigate the association betweencertain ceramide species, coronary artery stenosis and acute coronary syndrome. METHODS: Five hundred fifty-three patients with definite or suspected CAD were recruited and received angiography. Subjects were assigned into 4 groups according to the severity of coronary artery stenosis. The measurements of 4 plasma ceramide species, namely, Cer (d18:1/16:0), Cer (d18:1/18:0), Cer (d18:1/24:1), Cer (d18:1/24:0) were carried out by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the ratio of Cer (d18:1/16:0), Cer (d18:1/18:0) and Cer (d18:1/24:1) to Cer (18:1/24:0), respectively, were calculated as index to evaluate the association between plasma ceramides levels and coronary artery stenosis. Multiple logistic regression analysis was used to establish the prognostic model for the prediction of ACS risk. RESULTS: After the adjustment by multiple clinical risk factors including age, gender, pre-existing myocardial/cerebral infarction, hemoglobin A1c% (HbA1c%), smoking and the diagnosis during index hospitalization, multiple logistic regression analysis showed that the high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c%, unstable angina (UAP) and acute myocardial infarction (AMI) diagnosis (compared with atherosclerosis) during index hospitalization were associated with more severe coronary artery stenosis. Furthermore, the prognostic model was established after adjustment of risk factors and the area under curve (AUC) of receiver operating characteristics (ROC) for the prognostic model was 0.732 and 95% CI was 0.642–0.822. CONCLUSION: The severity of coronary artery stenosis is associated with high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c% and AMI. Although the reported prognostic model showed a good discrimination, further investigation on long term MACE is needed to evaluate the role of ceramide for the prediction of MACE risk. BioMed Central 2020-06-25 /pmc/articles/PMC7315545/ /pubmed/32586390 http://dx.doi.org/10.1186/s12944-020-01329-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tu, Chenchen Xie, Lan Wang, Zhenjie Zhang, Lili Wu, Hongmei Ni, Wei Li, Caixia Li, Lin Zeng, Yong Association between ceramides and coronary artery stenosis in patients with coronary artery disease |
title | Association between ceramides and coronary artery stenosis in patients with coronary artery disease |
title_full | Association between ceramides and coronary artery stenosis in patients with coronary artery disease |
title_fullStr | Association between ceramides and coronary artery stenosis in patients with coronary artery disease |
title_full_unstemmed | Association between ceramides and coronary artery stenosis in patients with coronary artery disease |
title_short | Association between ceramides and coronary artery stenosis in patients with coronary artery disease |
title_sort | association between ceramides and coronary artery stenosis in patients with coronary artery disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315545/ https://www.ncbi.nlm.nih.gov/pubmed/32586390 http://dx.doi.org/10.1186/s12944-020-01329-0 |
work_keys_str_mv | AT tuchenchen associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT xielan associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT wangzhenjie associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT zhanglili associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT wuhongmei associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT niwei associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT licaixia associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT lilin associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease AT zengyong associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease |